But a consistent thread in negative reviews describes slow response times, difficulty reaching support when issues arise, and limited options for resolution when problems occur
Learn More About Retatrutide What is Retatrutide Retatrutide is a first-in-class synthetic peptide developed by Eli Lilly that simultaneously activates three hormone receptors glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon that together govern appetite, metabolism, insulin sensitivity, energy expenditure, and fat oxidation
Bailey CJ, Gross JL, Hennicken D, Iqbal N, Mansfield TA, List JF
Anthem Medicare Advantage plans follow CMS guidelines on GLP-1 coverage, with limited flexibility to add benefits beyond what traditional Medicare covers
their 53-year-old mother died after receiving illicit semaglutide injections at a beauty salon in May 2025